Immuron Ltd (IMRN) stock
IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.87−0.03 (-3.20%)
Close on Nov 17, 2026Market cap $7.03MP/E –Yield –
Immuron cash
Cash and short-term investments held at the end of each period.
Immuron's cash was A$9.02M at Jun 30, 2026. For fiscal 2026 it was A$9.02M, up 218.6% from the year before. Over ten years it grew 14.7% a year on average. The highest annual figure on record is A$25.05M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | A$9.02M | +218.6% |
| FY2025 | Jun 30, 2025 | A$2.83M | -75.7% |
| FY2024 | Jun 30, 2024 | A$11.66M | -32.1% |
| FY2023 | Jun 30, 2023 | A$17.16M | -22.4% |
| FY2022 | Jun 30, 2022 | A$22.11M | -11.7% |
| FY2021 | Jun 30, 2021 | A$25.05M | +670.6% |
| FY2020 | Jun 30, 2020 | A$3.25M | -36.5% |
| FY2019 | Jun 30, 2019 | A$5.12M | +8.3% |
| FY2018 | Jun 30, 2018 | A$4.73M | +18.3% |
| FY2017 | Jun 30, 2017 | A$3.99M | +74.4% |
| FY2016 | Jun 30, 2016 | A$2.29M | -26.5% |
| FY2015 | Jun 30, 2015 | A$3.12M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | A$9.02M | -59.2% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | A$2.83M | -88.7% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | A$11.66M | +258.6% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | A$17.16M | +235.2% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | A$22.11M | +367.7% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | A$25.05M | +527.0% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | A$3.25M | +41.9% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | A$5.12M | +64.3% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | A$4.73M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | A$3.99M | – |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | A$2.29M | – |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | A$3.12M | – |
See a number that looks wrong?